Photography or Video in Assessing Breast Reconstruction?
Launched by NHS GREATER GLASGOW AND CLYDE · Mar 2, 2012
Trial Information
Current as of June 12, 2025
Completed
Keywords
ClinConnect Summary
Breast cancer is the commonest cancer to affect women in the UK. Current guidelines state that; disease permitting, all females due to undergo mastectomy for breast cancer should be offered reconstruction. This usually takes place in the form of implant based reconstruction, regional flap based reconstruction +/- implant or free autologous tissue based reconstruction.
Traditional methods of subjectively assessing the aesthetic outcome of any of the forms of breast surgery have been shown to be poor and the assessment of immediate reconstructions a cumbersome task. The qualitative part of t...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female patient
- • Minimum 18 years of age
- • Due to attend for Nipple areola complex tattooing
- • Previous unilateral breast reconstruction following mastectomy
- Exclusion Criteria:
- • Male patient
- • Bilateral Breast Reconstruction
- • Reconstruction less than 1year ago
- • Breast reconstruction not following breast cancer excision
About Nhs Greater Glasgow And Clyde
NHS Greater Glasgow and Clyde (NHS GG&C) is one of the largest health organizations in the UK, dedicated to delivering high-quality healthcare services to a diverse population. As a clinical trial sponsor, NHS GG&C plays a pivotal role in advancing medical research and improving patient outcomes through innovative clinical studies. The organization is committed to upholding rigorous ethical standards and regulatory compliance, ensuring that all trials are conducted with the utmost care for participant safety and scientific integrity. With a focus on collaboration, NHS GG&C partners with academic institutions, healthcare professionals, and industry stakeholders to foster an environment conducive to groundbreaking research and the development of new therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Glasgow, , United Kingdom
Patients applied
Trial Officials
Adam Gilmour, MBChB, MRCS(Ed)
Principal Investigator
NHS Greater Glasgow & Clyde
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials